K2 BIOLABS, INC.

K2 BIOLABS, INC. specializes in advanced biological research and laboratory support services, delivering technical expertise in biosafety, molecular diagnostics, and bioanalytical instrumentation. The company provides end-to-end laboratory operations including sample processing, assay development, data analysis, and compliance-driven documentation for regulated environments. Their technical capabilities encompass PCR-based diagnostics, next-generation sequencing workflows, biospecimen management, and adherence to CLIA, CAP, and GLP standards. K2 BIOLABS differentiates itself through precision-driven experimental design, rapid turnaround for time-sensitive biological testing, and robust quality control protocols tailored to federal research and public health needs. Award history is not available to identify specific agency relationships or contracting patterns. As such, no definitive agency experience can be inferred from the provided data. The company’s primary NAICS code, 541690, reflects its focus on scientific research and development services outside the scope of traditional engineering or medical labs. In practice, this means K2 BIOLABS operates as a contract research organization supporting government-funded life sciences initiatives, including infectious disease surveillance, environmental biohazard analysis, and biodefense-related diagnostics. Their market positioning centers on niche, high-compliance biological research services with an emphasis on reproducibility and regulatory alignment. K2 BIOLABS, INC. is a small business structured as a 2L entity, with no government certifications on record. The company is headquartered in Houston, Texas, and maintains a localized operational footprint focused on serving federal and state-level research institutions in the Gulf Coast region. While lacking formal certifications, its technical operations are grounded in industry-standard laboratory practices and quality management systems aligned with federal research requirements.